Skip to content

Inspection Record

Neva Analytics, LLC — FDA 483 Findings

US FDAInspected 2026-04-01Published 2026-11-12 8 findingsOther quality systemDeviation, CAPA, and investigationLaboratory and QC controlsComputer system validationComplaint and recall handlingQuality unit oversight

Inspectors Inga M WarrThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Refrigerator _ ()(4) stored USP References used to execute HPLC assays.

2Deviation, CAPA, and investigation

Standard Operating Procedure, SOP-1005.00, “Handling Deviations & CAPA” needed clarity on how System Suitability failures occurring in the HPLC are to be resolved.

3Laboratory and QC controls

Laboratory records do not include the initials or signature of a second person showing that the original records have been reviewed for accuracy, completeness and compliance with established standards.

4Computer system validation

Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.

5Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.

6Computer system validation

A written record of the program along with appropriate validation data has not been maintained in situations where backup data is eliminated by computerization or other automated processes.

7Complaint and recall handling

Procedures describing the handling of written and oral complaints related to drug products are not written or followed.

8Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-11-12. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Neva Analytics, LLC company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.